Lavipharm SA
ATHEX:LAVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lavipharm SA
ATHEX:LAVI
|
GR |
|
CMC Markets PLC
LSE:CMCX
|
UK |
|
Columbia Sportswear Co
NASDAQ:COLM
|
US |
|
Powersoft SpA
MIL:PWS
|
IT |
|
C
|
Canon Marketing Japan Inc
XMUN:CNJ
|
JP |
|
Westamerica Bancorp
NASDAQ:WABC
|
US |
|
Bridgestone Corp
F:BGT
|
JP |
Wall St Price Targets
LAVI Price Targets Summary
Lavipharm SA
According to Wall Street analysts, the average 1-year price target for LAVI is 2.122 EUR with a low forecast of 2.101 EUR and a high forecast of 2.184 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LAVI's stock price target?
Price Target
2.122
EUR
According to Wall Street analysts, the average 1-year price target for LAVI is 2.122 EUR with a low forecast of 2.101 EUR and a high forecast of 2.184 EUR.
What is the Revenue forecast for Lavipharm SA?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 3 years is 37%.
What is the Gross Profit forecast for Lavipharm SA?
Projected CAGR
38%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 38%.
What is the Operating Income forecast for Lavipharm SA?
Projected CAGR
62%
The compound annual growth rate for Operating Income over the next 3 years is 62%.
What is the Pre-Tax Income forecast for Lavipharm SA?
Projected CAGR
71%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 71%.
What is the Net Income forecast for Lavipharm SA?
Projected CAGR
70%
The compound annual growth rate for Net Income over the next 3 years is 70%.
